Anti-CD45 ( DrugBank: - )

3 diseases

60. 再生不良性貧血

臨床試験数 : 245 / 薬物数 : 318 - (DrugBank : 86) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 166

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00590460 (ClinicalTrials.gov)	July 2001	26/12/2007	Antibody Conditioning Regimen For Allogeneic Donor Stem Cell Transplantation Of Patients With Fancon ...	Cd45 (Yth-24 and Yth 54) and Cd52 (Campath-1H) Monoclonal Antibody Conditioning Regimen for Allogene ...	Fanconi Anemia;Severe Aplastic Anemia	Biological: CAMPATH-1H;Biological: Anti-CD45;Drug: Fludarabine;Procedure: Stem cell infusion	Baylor College of Medicine	The Methodist Hospital System;Center for Cell and Gene Therapy, Baylor College of Medicine	Terminated	N/A	N/A	All	5	Phase 1/Phase 2	United States

臨床試験数 : 500 / 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00579137 (ClinicalTrials.gov)	October 2007	19/12/2007	Allogeneic SCT Of Pts With SCID And Other Primary Immunodeficiency Disorders	CD45 and Alemtuzumab Monoclonal Antibody Conditioning Regimen For Allogeneic Donor Stem Cell Transpl ...	Severe Combined Immunodeficiency Disease;Severe Primary Immunodeficiency Disorder;Undefined T Cell D ...	Biological: Campath -1H;Drug: Fludarabine;Biological: Anti-CD45;Procedure: Stem cell infusion	Baylor College of Medicine	Center for Cell and Gene Therapy, Baylor College of Medicine;Texas Children's Hospital	Terminated	N/A	N/A	All	3	Phase 1/Phase 2	United States

臨床試験数 : 62 / 薬物数 : 93 - (DrugBank : 30) / 標的遺伝子数 : 30 - 標的パスウェイ数 : 144

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00586274 (ClinicalTrials.gov)	March 2002	21/12/2007	Use of Rft5-Dga to Deplete Alloreactive Cells for Pts With Fanconi Anemia After Haploidentical SCT	A Phase I Study Evaluating The Use Of Rft5-Dga To Deplete Alloreactive Cells For Patients With Fanco ...	FANCONI ANEMIA	Procedure: CD34 selected haploidentical PBSCT;Drug: Fludarabine;Biological: T cell infusion;Biologic ...	Baylor College of Medicine	UTSW-Dallas;Center for Cell and Gene Therapy, Baylor College of Medicine	Terminated	N/A	64 Years	Both	1	Phase 1	United States
2	NCT00590460 (ClinicalTrials.gov)	July 2001	26/12/2007	Antibody Conditioning Regimen For Allogeneic Donor Stem Cell Transplantation Of Patients With Fancon ...	Cd45 (Yth-24 and Yth 54) and Cd52 (Campath-1H) Monoclonal Antibody Conditioning Regimen for Allogene ...	Fanconi Anemia;Severe Aplastic Anemia	Biological: CAMPATH-1H;Biological: Anti-CD45;Drug: Fludarabine;Procedure: Stem cell infusion	Baylor College of Medicine	The Methodist Hospital System;Center for Cell and Gene Therapy, Baylor College of Medicine	Terminated	N/A	N/A	All	5	Phase 1/Phase 2	United States